title: Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1.
abstract: Estrogen receptor (ER) signaling plays an important role in breast cancer progression, and ER functions are influenced by coregulatory proteins. PELP1 (proline-, glutamic acid-, and leucine-rich protein 1) is a nuclear receptor coregulator that plays an important role in ER signaling. Its expression is deregulated in hormonal cancers. We identified PELP1 as a novel cyclin-dependent kinase (CDK) substrate. Using site-directed mutagenesis and in vitro kinase assays, we identified Ser(477) and Ser(991) of PELP1 as CDK phosphorylation sites. Using the PELP1 Ser(991) phospho-specific antibody, we show that PELP1 is hyperphosphorylated during cell cycle progression. Model cells stably expressing the PELP1 mutant that lack CDK sites had defects in estradiol (E2)-mediated cell cycle progression and significantly affected PELP1-mediated oncogenic functions in vivo. Mechanistic studies showed that PELP1 modulates transcription factor E2F1 transactivation functions, that PELP1 is recruited to pRb/E2F target genes, and that PELP1 facilitates ER signaling cross talk with cell cycle machinery. We conclude that PELP1 is a novel substrate of interphase CDKs and that its phosphorylation is important for the proper function of PELP1 in modulating hormone-driven cell cycle progression and also for optimal E2F transactivation function. Because the expression of both PELP1 and CDKs is deregulated in breast tumors, CDK-PELP1 interactions will have implications in breast cancer progression.
authors.affiliation: Department of Obstetrics and Gynecology, University of Texas Health Science Center, 7703 Floyd Curl Drive, Mail Code 7836, San Antonio, TX 78229-3900, USA.
authors.forename: Binoj C
authors.initials: BC
authors.lastname: Nair
authors.forename: Sujit S
authors.initials: SS
authors.lastname: Nair
authors.forename: Dimple
authors.initials: D
authors.lastname: Chakravarty
authors.forename: Rambabu
authors.initials: R
authors.lastname: Challa
authors.forename: Bramanandam
authors.initials: B
authors.lastname: Manavathi
authors.forename: P Renee
authors.initials: PR
authors.lastname: Yew
authors.forename: Rakesh
authors.initials: R
authors.lastname: Kumar
authors.forename: Rajeshwar Rao
authors.initials: RR
authors.lastname: Tekmal
authors.forename: Ratna K
authors.initials: RK
authors.lastname: Vadlamudi
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000201:enzymology / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D002453:Cell Cycle / Q000502:physiology; D045744:Cell Line, Tumor; D056970:Co-Repressor Proteins; D051357:Cyclin-Dependent Kinase 2 / Q000235:genetics / Q000378:metabolism; D018844:Cyclin-Dependent Kinases / Q000235:genetics / Q000378:metabolism*; D050684:E2F Transcription Factors / Q000235:genetics / Q000378:metabolism; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009154:Mutation; D041681:NIH 3T3 Cells; D010766:Phosphorylation; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors
chemical_list: D056970:Co-Repressor Proteins; D050684:E2F Transcription Factors; C438485:PELP1 protein, human; D015534:Trans-Activators; D014157:Transcription Factors; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases
references.citation: J Biol Chem. 2004 Dec 3;279(49):50930-41
references.pmid: 15456770
references.citation: Cancer Res. 2005 Jul 1;65(13):5571-7
references.pmid: 15994929
references.citation: Cancer Res. 2007 Jun 1;67(11):5505-12
references.pmid: 17545633
references.citation: Bioorg Med Chem Lett. 2000 Mar 6;10(5):461-4
references.pmid: 10743948
references.citation: Mol Cell. 2007 Jul 6;27(1):107-19
references.pmid: 17612494
references.citation: Mol Cancer Res. 2008 May;6(5):851-61
references.pmid: 18505929
references.citation: EMBO Rep. 2010 Jun;11(6):438-44
references.pmid: 20448663
references.citation: Cell. 2005 Jun 17;121(6):873-85
references.pmid: 15960975
references.citation: Mol Cell Biol. 2000 Dec;20(23):8667-75
references.pmid: 11073968
references.citation: Mol Cell Biol. 2001 Feb;21(3):794-810
references.pmid: 11154267
references.citation: Nucl Recept Signal. 2007 May 17;5:e004
references.pmid: 17525794
references.citation: BMC Med Imaging. 2008 Oct 16;8:16
references.pmid: 18925932
references.citation: Life Sci. 1996 May 24;58(26):2447-53
references.pmid: 8691990
references.citation: J Biol Chem. 2007 Oct 12;282(41):29902-9
references.pmid: 17704056
references.citation: Mol Cell Biol. 1997 Sep;17(9):5338-47
references.pmid: 9271411
references.citation: Mol Endocrinol. 2006 Dec;20(12):3279-92
references.pmid: 16916940
references.citation: Trends Endocrinol Metab. 2001 Sep;12(7):320-7
references.pmid: 11504672
references.citation: J Surg Oncol. 1986 Apr;31(4):229-34
references.pmid: 3724177
references.citation: Mol Cell Biol. 1998 Aug;18(8):4499-508
references.pmid: 9671459
references.citation: Breast Cancer Res Treat. 2010 Apr;120(3):603-12
references.pmid: 19495959
references.citation: Hum Pathol. 2005 Jun;36(6):670-5
references.pmid: 16021574
references.citation: Mol Cell Biol. 2009 May;29(10):2582-93
references.pmid: 19307310
references.citation: Dev Cell. 2006 May;10(5):563-73
references.pmid: 16678773
references.citation: Nature. 2005 Mar 3;434(7029):104-8
references.pmid: 15744308
references.citation: Oncogene. 1996 Jun 6;12(11):2315-24
references.pmid: 8649771
references.citation: J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):169-74
references.pmid: 9699870
references.citation: Cancer Res. 2004 Sep 15;64(18):6416-23
references.pmid: 15374949
references.citation: Cell. 2006 Nov 3;127(3):635-48
references.pmid: 17081983
references.citation: J Biol Chem. 1997 Apr 18;272(16):10882-94
references.pmid: 9099745
references.citation: Cell. 1989 Sep 22;58(6):1085-95
references.pmid: 2673542
references.citation: J Biol Chem. 2003 Jun 13;278(24):22119-27
references.pmid: 12682072
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10453-8
references.pmid: 9724724
references.citation: Science. 1996 Dec 6;274(5293):1672-7
references.pmid: 8939849
references.citation: Int J Cancer. 2002 Dec 10;102(5):463-8
references.pmid: 12432547
references.citation: Cancer Cell. 2004 Jun;5(6):575-85
references.pmid: 15193260
references.citation: Proc Natl Acad Sci U S A. 2007 May 29;104(22):9381-6
references.pmid: 17517653